A study on 110 patients evaluated if MR radiomics from brain metastasis originated from lung cancer was shown to associate with EGFR, ALK and KRAS mutations and reported excellent model performances for all three tissue biomarkers (AUC > 0.9, LOOCV) [102]. The gene discussed is KRAS; the disease is lung cancer.